Načítá se...
Gene Therapy for the Treatment of Primary Immune Deficiencies
The use of gene therapy in the treatment of primary immune deficiencies (PID) has advanced significantly in the last decade. Clinical trials for X-linked severe combined immunodeficiency, adenosine deaminase deficiency (ADA), chronic granulomatous disease, and Wiskott-Aldrich syndrome have demonstra...
Uloženo v:
| Vydáno v: | Curr Allergy Asthma Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909980/ https://ncbi.nlm.nih.gov/pubmed/27056559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11882-016-0615-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|